HNB
IMVT icon

Huntington National Bank’s Immunovant IMVT Stock Holding History

Huntington National Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.88K Hold
116
– – ﹤0.01% 2194
2025
Q4 		$2.95K Buy
+116
New +$2.59K ﹤0.01% 2118
2025
Q2 		– Sell
-158
Closed -$2.7K – 4190
2025
Q1 		$2.7K Buy
+158
New +$3.31K ﹤0.01% 2153

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Huntington National Bank's IMVT Position: Q1 2026 in Review

Huntington National Bank held its Immunovant (IMVT) position steady in Q1 2026 at 116 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Huntington National Bank first reported a position in IMVT in Q1 2025 and has held it in 3 quarters since. The position peaked at $2.95K in Q4 2025. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Huntington National Bank held 116 shares of Immunovant worth $2.88K as of Q1 2026.
  • Huntington National Bank left its Immunovant share count unchanged in Q1 2026.
  • Immunovant made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2194 holding.
  • Huntington National Bank first reported a position in Immunovant in Q1 2025 and has held it in 3 quarters since.
  • Huntington National Bank's Immunovant position peaked at $2.95K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.